Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

iRhom2 inhibits bile duct obstruction-induced liver fibrosis.

Sundaram B, Behnke K, Belancic A, Al-Salihi MA, Thabet Y, Polz R, Pellegrino R, Zhuang Y, Shinde PV, Xu HC, Vasilevska J, Longerich T, Herebian D, Mayatepek E, Bock HH, May P, Kordes C, Aghaeepour N, Mak TW, Keitel V, Häussinger D, Scheller J, Pandyra AA, Lang KS, Lang PA.

Sci Signal. 2019 Oct 29;12(605). pii: eaax1194. doi: 10.1126/scisignal.aax1194.

PMID:
31662486
2.

Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction.

Schmidleithner L, Thabet Y, Schönfeld E, Köhne M, Sommer D, Abdullah Z, Sadlon T, Osei-Sarpong C, Subbaramaiah K, Copperi F, Haendler K, Varga T, Schanz O, Bourry S, Bassler K, Krebs W, Peters AE, Baumgart AK, Schneeweiss M, Klee K, Schmidt SV, Nüssing S, Sander J, Ohkura N, Waha A, Sparwasser T, Wunderlich FT, Förster I, Ulas T, Weighardt H, Sakaguchi S, Pfeifer A, Blüher M, Dannenberg AJ, Ferreirós N, Muglia LJ, Wickenhauser C, Barry SC, Schultze JL, Beyer M.

Immunity. 2019 May 21;50(5):1232-1248.e14. doi: 10.1016/j.immuni.2019.03.014. Epub 2019 Apr 23.

PMID:
31027998
3.

Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.

Thabet Y, Klingmann V, Breitkreutz J.

J Clin Pharmacol. 2018 Oct;58 Suppl 10:S26-S35. doi: 10.1002/jcph.1138. Review.

PMID:
30248193
4.

Comparative study on disintegration methods for oral film preparations.

Speer I, Steiner D, Thabet Y, Breitkreutz J, Kwade A.

Eur J Pharm Biopharm. 2018 Nov;132:50-61. doi: 10.1016/j.ejpb.2018.09.005. Epub 2018 Sep 7.

PMID:
30201569
5.

Continuous inkjet printing of enalapril maleate onto orodispersible film formulations.

Thabet Y, Lunter D, Breitkreutz J.

Int J Pharm. 2018 Jul 30;546(1-2):180-187. doi: 10.1016/j.ijpharm.2018.04.064. Epub 2018 May 16.

PMID:
29753906
6.

Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.

Thabet Y, Lunter D, Breitkreutz J.

Eur J Pharm Sci. 2018 May 30;117:236-244. doi: 10.1016/j.ejps.2018.02.030. Epub 2018 Feb 27.

PMID:
29499348
7.

Flexible and precise dosing of enalapril maleate for all paediatric age groups utilizing orodispersible minitablets.

Thabet Y, Walsh J, Breitkreutz J.

Int J Pharm. 2018 Apr 25;541(1-2):136-142. doi: 10.1016/j.ijpharm.2018.02.037. Epub 2018 Feb 21.

PMID:
29474896
8.

10 years EU regulation of pediatric medicines - impact on cardiovascular drug formulations.

Thabet Y, Slavkova M, Breitkreutz J.

Expert Opin Drug Deliv. 2018 Mar;15(3):261-270. doi: 10.1080/17425247.2018.1420054. Epub 2017 Dec 28. Review.

PMID:
29284286
9.

Orodispersible films: Product transfer from lab-scale to continuous manufacturing.

Thabet Y, Breitkreutz J.

Int J Pharm. 2018 Jan 15;535(1-2):285-292. doi: 10.1016/j.ijpharm.2017.11.021. Epub 2017 Nov 13.

PMID:
29146537
10.

Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection.

Beyer M, Abdullah Z, Chemnitz JM, Maisel D, Sander J, Lehmann C, Thabet Y, Shinde PV, Schmidleithner L, Köhne M, Trebicka J, Schierwagen R, Hofmann A, Popov A, Lang KS, Oxenius A, Buch T, Kurts C, Heikenwalder M, Fätkenheuer G, Lang PA, Hartmann P, Knolle PA, Schultze JL.

Nat Immunol. 2016 May;17(5):593-603. doi: 10.1038/ni.3399. Epub 2016 Mar 7.

PMID:
26950238
11.

Corrigendum: Efficient genome engineering by targeted homologous recombination in mouse embryos using transcription activator-like effector nucleases.

Sommer D, Peters AE, Wirtz T, Mai M, Ackermann J, Thabet Y, Schmidt J, Weighardt H, Wunderlich FT, Degen J, Schultze JL, Beyer M.

Nat Commun. 2015 Feb 20;6:5927. doi: 10.1038/ncomms6927. No abstract available.

PMID:
25698449
12.

The contribution of epigenetics in Sjögren's Syndrome.

Konsta OD, Thabet Y, Le Dantec C, Brooks WH, Tzioufas AG, Pers JO, Renaudineau Y.

Front Genet. 2014 Apr 3;5:71. doi: 10.3389/fgene.2014.00071. eCollection 2014. Review.

13.

Efficient genome engineering by targeted homologous recombination in mouse embryos using transcription activator-like effector nucleases.

Sommer D, Peters A, Wirtz T, Mai M, Ackermann J, Thabet Y, Schmidt J, Weighardt H, Wunderlich FT, Degen J, Schultze JL, Beyer M.

Nat Commun. 2014;5:3045. doi: 10.1038/ncomms4045. Erratum in: Nat Commun. 2015;6:5927.

PMID:
24413636
14.

DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus.

Fali T, Le Dantec C, Thabet Y, Jousse S, Hanrotel C, Youinou P, Brooks WH, Perl A, Renaudineau Y.

Autoimmunity. 2014 Jun;47(4):265-71. doi: 10.3109/08916934.2013.826207. Epub 2013 Oct 14.

15.

The IDO1-induced kynurenines play a major role in the antimicrobial effect of human myeloid cells against Listeria monocytogenes.

Niño-Castro A, Abdullah Z, Popov A, Thabet Y, Beyer M, Knolle P, Domann E, Chakraborty T, Schmidt SV, Schultze JL.

Innate Immun. 2014 May;20(4):401-11. doi: 10.1177/1753425913496442. Epub 2013 Aug 12.

PMID:
23940074
16.

Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells.

Thabet Y, Le Dantec C, Ghedira I, Devauchelle V, Cornec D, Pers JO, Renaudineau Y.

J Autoimmun. 2013 Mar;41:175-81. doi: 10.1016/j.jaut.2013.02.002. Epub 2013 Mar 7.

PMID:
23478041
17.

Anti-Saccharomyces cerevisiae antibodies are elevated in Graves' disease but not in Hashimoto's thyroiditis.

Mankaï A, Thabet Y, Manoubi W, Achour A, Sakly W, Ghedira I.

Endocr Res. 2013;38(2):98-104. doi: 10.3109/07435800.2012.723293. Epub 2012 Sep 19.

PMID:
22992126
18.

Altered patterns of epigenetic changes in systemic lupus erythematosus and auto-antibody production: is there a link?

Thabet Y, Cañas F, Ghedira I, Youinou P, Mageed RA, Renaudineau Y.

J Autoimmun. 2012 Sep;39(3):154-60. doi: 10.1016/j.jaut.2012.05.015. Epub 2012 Jun 16. Review.

PMID:
22709855
19.

Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus.

Mankaï A, Sakly W, Thabet Y, Achour A, Manoubi W, Ghedira I.

Rheumatol Int. 2013 Mar;33(3):665-9. doi: 10.1007/s00296-012-2431-3. Epub 2012 Apr 10.

PMID:
22527140
20.

Performance of anti-deamidated gliadin peptides antibodies in celiac disease diagnosis.

Sakly W, Mankaï A, Ghdess A, Achour A, Thabet Y, Ghedira I.

Clin Res Hepatol Gastroenterol. 2012 Dec;36(6):598-603. doi: 10.1016/j.clinre.2012.01.008. Epub 2012 Mar 20.

PMID:
22436429
21.

Thyroid-related autoantibodies in Tunisian patients with type 1 diabetes.

Sakly W, Mankaï A, Achour A, Thabet Y, Ouertani M, Boughammoura L, Harbi A, Chaieb L, Sfar MT, Ghedira I.

Endocr Res. 2012;37(2):59-66. doi: 10.3109/07435800.2011.639318. Epub 2011 Dec 9.

PMID:
22149460
22.

Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation.

Beyer M, Thabet Y, Müller RU, Sadlon T, Classen S, Lahl K, Basu S, Zhou X, Bailey-Bucktrout SL, Krebs W, Schönfeld EA, Böttcher J, Golovina T, Mayer CT, Hofmann A, Sommer D, Debey-Pascher S, Endl E, Limmer A, Hippen KL, Blazar BR, Balderas R, Quast T, Waha A, Mayer G, Famulok M, Knolle PA, Wickenhauser C, Kolanus W, Schermer B, Bluestone JA, Barry SC, Sparwasser T, Riley JL, Schultze JL.

Nat Immunol. 2011 Aug 14;12(9):898-907. doi: 10.1038/ni.2084.

23.

Anti-cardiolipin and anti-beta 2-glycoprotein I antibodies in celiac disease.

Mankaï A, Achour A, Thabet Y, Manoubia W, Sakly W, Ghedira I.

Pathol Biol (Paris). 2012 Oct;60(5):291-5. doi: 10.1016/j.patbio.2011.07.003. Epub 2011 Aug 11.

PMID:
21839587
24.

Systemic lupus erythematosus in the elderly.

Achour A, Mankaï A, Thabet Y, Sakly W, Braham F, Kechrid C, Bahri F, Bouajina E, Chouchène S, Haddad O, Ghedira I.

Rheumatol Int. 2012 May;32(5):1225-9. doi: 10.1007/s00296-010-1744-3. Epub 2011 Jan 22.

PMID:
21258803
25.

IgA anti-actin antibodies in celiac disease.

Achour A, Thabet Y, Sakly W, Mankai A, Sakly N, Ayadi A, Sfar MT, Amri F, Harbi A, Essoussi AS, Krifa A, Ajmi S, Ghedira I.

Gastroenterol Clin Biol. 2010 Sep;34(8-9):483-7. doi: 10.1016/j.gcb.2010.01.023. Epub 2010 Jul 23.

26.

Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes.

Sakly W, Mankaï A, Sakly N, Thabet Y, Achour A, Ghedira-Besbes L, Jeddi M, Ghedira I.

Endocr Pathol. 2010 Jun;21(2):108-14. doi: 10.1007/s12022-010-9118-7.

PMID:
20387011

Supplemental Content

Loading ...
Support Center